On Thursday, November 12, 2026, the US stock market has the following top movers:
Top gainers:
1. (small‑cap; highly speculative) (POAS) +367.4% (intraday, morning scan)([alphadashpro.com](https://alphadashpro.com/premarket-gainers/?utm_source=openai)): Explosive move driven by day‑trader momentum rather than fundamentals; pre‑market scanners show extreme relative volume (~200x), suggesting a low‑float squeeze or news catalyst, but details are not yet widely reported. Treat this as a trading anomaly, not an investable signal.
2. Children’s Place (likely) (PLCE) +307.5% (intraday, morning scan)([alphadashpro.com](https://alphadashpro.com/premarket-gainers/?utm_source=openai)): Massive rebound on very high volume, probably tied to a balance‑sheet or strategic announcement (restructuring, financing, or deal speculation). The move size indicates short covering and momentum trading more than a measured response to fundamentals.
3. Paramount Global (PARA) +79.1% (intraday, morning scan)([alphadashpro.com](https://alphadashpro.com/premarket-gainers/?utm_source=openai)): Large-cap media stock spiking on deal speculation and/or renewed streaming/asset‑sale chatter. Given the magnitude and the stock’s history, the move likely reflects a short squeeze plus hopes for a strategic transaction rather than confirmed fundamentals.
Top losers:
1. Nebius Group (NBIS) ‑16.9% to ‑17.6% (intraday)([gainerslosers.com](https://gainerslosers.com/losers?sort=mcap&utm_source=openai)): Shares are sliding after the company’s Q3 2026 earnings disappointed; a weak outlook versus high expectations is driving a sharp de‑rating, with elevated volume indicating institutions are trimming positions following the call.
2. Keurig Dr Pepper (KDP) about ‑6.6% to ‑7.1% on the day([gainerslosers.com](https://gainerslosers.com/losers?sort=mcap&utm_source=openai)): Stock is under pressure after the company announced a $2 billion equity offering to reduce debt. The dilution and signal of balance‑sheet stress are weighing on sentiment, leading to accelerated selling.
3. Moderna (MRNA) about ‑6.5% on the day([gainerslosers.com](https://gainerslosers.com/losers?sort=mcap&utm_source=openai)): Continuing multi‑day decline as investors reassess long‑term vaccine and pipeline revenue. With limited fresh positive news and risk‑off behavior in parts of biotech, traders are taking profits and rotating toward more immediate cash‑flow stories.